Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Marisa Moroney

Concepts (101)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
4
2022
205
1.720
Why?
Wnt Signaling Pathway
2
2021
211
1.120
Why?
beta Catenin
3
2022
250
1.100
Why?
Ovarian Neoplasms
4
2020
604
0.950
Why?
Uterine Cervical Neoplasms
3
2022
269
0.770
Why?
Carcinoma, Endometrioid
2
2022
49
0.730
Why?
Wnt Proteins
1
2021
131
0.630
Why?
Surgical Oncology
1
2019
30
0.560
Why?
Adenocarcinoma, Mucinous
1
2018
76
0.500
Why?
Lymph Nodes
1
2018
511
0.430
Why?
Mutation
4
2022
4093
0.410
Why?
Neoplasm Recurrence, Local
2
2022
1160
0.380
Why?
Palliative Care
1
2019
1032
0.310
Why?
Gene Expression Regulation, Neoplastic
2
2021
1432
0.210
Why?
Enoxaparin
1
2024
68
0.200
Why?
Neoplasms
1
2019
2954
0.190
Why?
Genital Neoplasms, Female
1
2024
100
0.180
Why?
Pyridones
1
2024
210
0.180
Why?
Neoplasm Grading
2
2022
313
0.170
Why?
Treatment Adherence and Compliance
1
2021
27
0.170
Why?
Wnt4 Protein
1
2021
19
0.170
Why?
Genital Diseases, Female
1
2021
31
0.170
Why?
Genitalia, Female
1
2021
43
0.170
Why?
Heterocyclic Compounds, 3-Ring
1
2021
44
0.170
Why?
Indazoles
1
2021
86
0.160
Why?
Pyrazoles
1
2024
517
0.150
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.150
Why?
Imidazoles
1
2021
245
0.150
Why?
Disease Susceptibility
1
2021
339
0.150
Why?
DNA Polymerase II
1
2019
35
0.140
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
35
0.140
Why?
Chemotherapy, Adjuvant
1
2020
429
0.140
Why?
Microsatellite Instability
1
2019
57
0.140
Why?
Women's Health
1
2021
317
0.140
Why?
Tumor Suppressor Protein p53
2
2022
530
0.140
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
111
0.140
Why?
Molecular Targeted Therapy
1
2021
447
0.130
Why?
Cell Survival
1
2021
1105
0.130
Why?
Frozen Sections
1
2018
23
0.130
Why?
Recurrence
1
2021
1133
0.130
Why?
PTEN Phosphohydrolase
1
2019
166
0.130
Why?
Neoplasm Metastasis
1
2020
693
0.130
Why?
Neoadjuvant Therapy
1
2020
475
0.130
Why?
Female
11
2024
79499
0.130
Why?
Disease Management
1
2021
651
0.120
Why?
Pyridines
1
2021
610
0.120
Why?
Lymph Node Excision
1
2018
174
0.120
Why?
Tumor Microenvironment
1
2020
747
0.120
Why?
Biomarkers, Tumor
2
2022
1339
0.110
Why?
Adenocarcinoma
1
2022
927
0.110
Why?
Neoplasm Staging
1
2019
1488
0.110
Why?
Drug Resistance, Neoplasm
1
2020
893
0.110
Why?
Humans
12
2024
146342
0.100
Why?
Healthcare Disparities
1
2021
733
0.100
Why?
Patient Education as Topic
1
2019
770
0.100
Why?
Cell Line, Tumor
1
2021
3545
0.100
Why?
Middle Aged
6
2024
36619
0.090
Why?
Patient Care Team
1
2019
701
0.090
Why?
Membrane Proteins
1
2019
1130
0.090
Why?
Disease Progression
1
2020
2867
0.090
Why?
Antineoplastic Agents
2
2020
2219
0.090
Why?
Case-Control Studies
1
2019
3647
0.080
Why?
Postoperative Complications
1
2024
3034
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1998
0.080
Why?
Retrospective Studies
4
2024
17438
0.070
Why?
Inflammation
1
2020
2919
0.070
Why?
Aged
4
2024
26432
0.070
Why?
Quality of Life
1
2019
3200
0.060
Why?
Cross-Sectional Studies
1
2018
5899
0.060
Why?
Survival Rate
2
2021
2092
0.060
Why?
Gynecologic Surgical Procedures
1
2024
68
0.050
Why?
Prognosis
2
2024
4351
0.050
Why?
Follow-Up Studies
2
2024
5439
0.050
Why?
Cervix Uteri
1
2022
50
0.050
Why?
Factor Xa Inhibitors
1
2024
195
0.040
Why?
Adult
3
2021
41087
0.040
Why?
Sex Differentiation
1
2021
11
0.040
Why?
Sexual Development
1
2021
17
0.040
Why?
Mammary Glands, Human
1
2021
71
0.040
Why?
Clinical Trials, Phase I as Topic
1
2020
49
0.040
Why?
Uterus
1
2021
227
0.040
Why?
Venous Thromboembolism
1
2024
332
0.040
Why?
Anticoagulants
1
2024
746
0.030
Why?
Aged, 80 and over
2
2021
8391
0.030
Why?
Combined Modality Therapy
1
2020
1271
0.030
Why?
Survival Analysis
1
2020
1378
0.030
Why?
Guideline Adherence
1
2021
594
0.030
Why?
Socioeconomic Factors
1
2021
1327
0.030
Why?
Quality of Health Care
1
2021
702
0.030
Why?
Databases, Factual
1
2021
1493
0.030
Why?
Polymorphism, Single Nucleotide
1
2021
2240
0.020
Why?
Cohort Studies
1
2021
6077
0.020
Why?
Magnetic Resonance Imaging
1
2022
3926
0.020
Why?
Breast Neoplasms
1
2021
2418
0.020
Why?
Pregnancy
1
2021
7230
0.020
Why?
Treatment Outcome
1
2020
11821
0.010
Why?
Young Adult
1
2021
14330
0.010
Why?
Mice
1
2021
18297
0.010
Why?
United States
1
2021
16136
0.010
Why?
Adolescent
1
2021
22557
0.010
Why?
Animals
1
2021
38107
0.010
Why?
Moroney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)